Barclays analyst Balaji Prasad lowered the firm’s price target on Organon (OGN) to $24 from $26 and keeps an Overweight rating on the shares. The shares rallied post the Q4 report, owing to reaffirmation of steady fundamentals, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OGN: